Dengue Testing Market: By Product Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Other Tests), By End-user (Hospitals, Diagnostic Centers, and Other End-users) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Dengue Testing Market size was valued at USD 345.7 million in 2023 and is poised to grow at a CAGR of 4.2% from 2024 to 2030. Dengue testing involves various diagnostic procedures to detect dengue virus infection and assess its severity. These tests are crucial for early diagnosis and appropriate management of dengue fever, a mosquito-borne disease that affects millions globally each year. The increasing incidence of dengue fever, particularly in tropical and subtropical regions, is a key driver for the dengue testing market. According to the World Health Organization, dengue infections have increased dramatically in recent decades, with an estimated 390 million infections occurring annually. Government and healthcare professionals' initiatives to limit dengue spread are expected to boost the market's growth over the forecast period.

For instance, in May 2023 year, DoH-CHD ramped up its dengue fever campaign in Soccsksargen after the Regional Epidemiology and Surveillance Unit (RESU) recorded 854 dengue cases in the Philippines from January 1 to April 30 2023 year. Furthermore, technological advancements in testing methods, such as the development of rapid diagnostic tests and multiplex PCR assays, contribute to market growth by improving the speed and accuracy of diagnosis. The market is also benefiting from increased healthcare expenditure and a growing focus on preventive care in many countries challenges such as the lack of healthcare infrastructure in some endemic regions and the need for more sensitive and specific diagnostic tools may hinder market growth. Asia Pacific region held the major market share in 2023 and is expected to dominate the global Dengue Testing Market in the forecasted years.

Dengue Testing Market Key Developments:

In 2022, Abbott Laboratories launched the Panbio Dengue IgG/IgM Rapid Test Device, a rapid diagnostic test that can differentiate between primary and secondary dengue infections.

  • As a rapid diagnostic test, it provides quick results, typically within 15-20 minutes.
  • It can distinguish between primary and secondary dengue infections; it’s supposed to be an important feature as secondary infections are often more severe
  • Detection of Both IgG and IgM Antibodies, where IgM antibody presence denotes recent or current infection & IgG indicates past infection, in case both are present it shows the secondary infection.

In 2023, Roche Diagnostics introduced a new multiplex PCR test that can simultaneously detect dengue, Zika, and chikungunya viruses, aiming to improve differential diagnosis in regions where these diseases co-circulate.

  • ability to simultaneously detect three different viruses - dengue, Zika, and chikungunya.
  • It utilizes PCR-based Technology that make it highly sensitive and highly specific

Dengue Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.2%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Dengue Testing Market Dynamics

The increasing global incidence of dengue fever is a significant driver for the dengue testing market. Climate change and urbanization contribute to the expansion of mosquito habitats, leading to more frequent outbreaks. The need for early and accurate diagnosis to prevent severe complications drives demand for dengue testing. Growing awareness about dengue fever and improved healthcare infrastructure in endemic regions also boost market growth. Government initiatives for dengue control and surveillance in countries like Brazil, Singapore, and Malaysia further stimulate the market. Moreover, the rising focus of companies on adopting various business strategies, such as acquisition, partnerships, and product launches for dengue testing, is expected to fuel the market's growth. For instance, in September of the base year, the Central Drugs Standard Control Organization (CDSCO) approved Cosara Diagnostics to manufacture and distribute SARAGENE Dengue Test Kit. The test kit is a real-time polymerase chain reaction technology-based in vitro diagnostic test that uses Co-Diagnostics' patented CoPrimers technology. However, the market faces challenges such as the need for more sensitive and specific diagnostic tools, especially for early-stage detection. The seasonal nature of dengue outbreaks can lead to fluctuations in demand for testing.

Dengue Testing Market Segmentation

By Product Type
  • ELISA-based Tests
  • RT-PCR-based Tests
  • Dengue IgG/IgM Rapid Test
  • Other Tests
By End User
  • Hospitals
  • Diagnostic Centers
  • Other End-users

Frequently Asked Questions

Dengue Testing Market was valued at USD 345.7 million in 2023 and is expected to grow at a CAGR 4.2% from 2024 to 2030.

The Dengue Testing Market is segmented based on Product Type, End Userss, and Geography.

The leading players in the global Dengue Testing Market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, bioMérieux SA, Alere Inc., InBios International, Inc., Quest Diagnostics, Arkray Inc.

Historic years considered for the market study are 2019-2022, 2023 is considered as the base year for market estimation, and Seven years forecast is presented from 2024 – 2030.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019 - 2023), and forecast (2024 - 2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Dengue Testing Market Introduction 
2.1.Global Dengue Testing Market  - Taxonomy
2.2.Global Dengue Testing Market  - Definitions
2.2.1.Product Type 
2.2.2.End User
2.2.3.Region
3.Global Dengue Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Dengue Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Dengue Testing Market  By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. ELISA-based Tests
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. RT-PCR-based Tests
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Dengue IgG/IgM Rapid Test
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Other Tests
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Dengue Testing Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Diagnostic Centers
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Other End-users
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Dengue Testing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Dengue Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Product Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.ELISA-based Tests
8.1.2.RT-PCR-based Tests
8.1.3.Dengue IgG/IgM Rapid Test
8.1.4.Other Tests
8.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Diagnostic Centers
8.2.3.Other End-users
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Dengue Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.ELISA-based Tests
9.1.2.RT-PCR-based Tests
9.1.3.Dengue IgG/IgM Rapid Test
9.1.4.Other Tests
9.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Diagnostic Centers
9.2.3.Other End-users
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Dengue Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.ELISA-based Tests
10.1.2.RT-PCR-based Tests
10.1.3.Dengue IgG/IgM Rapid Test
10.1.4.Other Tests
10.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Diagnostic Centers
10.2.3.Other End-users
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Dengue Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.ELISA-based Tests
11.1.2.RT-PCR-based Tests
11.1.3.Dengue IgG/IgM Rapid Test
11.1.4.Other Tests
11.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Diagnostic Centers
11.2.3.Other End-users
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Dengue Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.ELISA-based Tests
12.1.2.RT-PCR-based Tests
12.1.3.Dengue IgG/IgM Rapid Test
12.1.4.Other Tests
12.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Diagnostic Centers
12.2.3.Other End-users
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Abbott Laboratories
13.2.2.Hoffmann-La Roche Ltd
13.2.3.Bio-Rad Laboratories Inc.
13.2.4.Thermo Fisher Scientific Inc.
13.2.5.Siemens Healthineers
13.2.6.bioMérieux SA
13.2.7.Alere Inc.
13.2.8.InBios International, Inc.
13.2.9.Quest Diagnostics
13.2.10.Arkray Inc.
14. Research Methodology 
15. Appendix and Abbreviations 
  • Abbott Laboratories
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • bioMérieux SA
  • Alere Inc.
  • InBios International, Inc.
  • Quest Diagnostics
  • Arkray Inc.

Adjacent Markets